Clinical application of reverse-transcription polymerase chain reaction and intravenous immunoglobulin for enterovirus encephalitis

Japanese Journal of Infectious Diseases

Volumn 61, Issue 1, 2008, Pages 18-24

  Cheng, Ming Fang ^a,b   Chen, Bao Chen ^a,b   Huang, Tsi Shu ^a,b   Hsieh, Kai Sheng ^a,b   Chen, Shu Nuan ^a,b   Liu, Yung Ching ^a,b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; GANCICLOVIR; IMMUNOGLOBULIN; OSELTAMIVIR; VIRUS RNA;

ADOLESCENT; ARTICLE; CEREBROSPINAL FLUID CULTURE; CHILD; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; ENTEROVIRUS; ENTEROVIRUS INFECTION; EPILEPSY; FEMALE; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INTERMETHOD COMPARISON; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; VIRUS CULTURE; VIRUS DETECTION; VIRUS ENCEPHALITIS; VIRUS ISOLATION;

CHILD, PRESCHOOL; CYTOKINES; ENCEPHALITIS, VIRAL; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; TAIWAN;

EID: 40349098238     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Ho, M., Chen, E.R., Hsu, K.H., et al. (1999): An epidemic of enterovirus 71 infection in Taiwan. N. Engl. J. Med., 341, 929-935.
2. Lin, T.Y., Twu, S.J., Ho, M.S., et al. (2003): Enterovirus 71 outbreaks, Taiwan: occurrence and recognition. Emerg. Infect. Dis., 9, 291-293.
3. Wang, J.R., Tsai, H.P., Chen, P.F., et al. (2000): An outbreak of enterovirus 71 infection in Taiwan, 1998. II. Laboratory diagnosis and genetic analysis. J. Clin. Virol., 17, 91-99.
4. Center for Disease Control, Taiwan (2006): Guidelines for treatment of severe enteroviral infection. p. 11. Clinical management and indication of IVIg usage for severe enterovirus infection (in Chinese).
5. Rotbart, H.A. and Romero, J.R. (1995): Laboratory diagnosis of enteroviral infections. p. 401-410. In H.A. Rotbart (ed.), Human Enterovinis Infections. ASM Press, Washington, D.C.
6. Holger, F.R., Alexandra, C., Gerhard, M., et al. (2002): Rapid detection of enterovirus infection by automated RNA extraction and real-time fluorescence PCR. J. Clin. Virol., 25, 155-164.
7. Rotbart, H.A. (1995): Meningitis and encephalitis. p. 271-289. In H. A. Rotbart (ed.), Human Enterovirus Infections. ASM Press, Washington, D.C.
8. Stanway, G. (2005): Family Picornaviridae. p. 757-758. In C.M. Fauquet, M.A. Mayo, J. Maniloff, et al. (ed.), Virus Taxonomy. Eighth Report of the International Committee on Taxonomy of Viruses. Elsevier/ Academic Press, London.
9. Jochem, M.D., Maria, T.E., Gerco, H.J., et al. (1997): Antibodies against enteroviruses in intravenous Ig preparations: great variation in titres and poor correlation with the incidence of circulating serotypes. J. Med. Virol., 53, 273-276.
10. Melnick, J.L. (1996): Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. p. 655-712. In B.N. Fields, D.M. Knipe, P.M. Howley (ed.), Virology. Lippincott-Raven Press, Philadelphia.
11. Nagington, J. (1982): Echovirus 11 infection and prophylactic antiserum [letter]. Lancet, 1, 446.
12. Carolane, D.J., Long, A.M., McKeever, P.A., et al. (1985): Prevention of spread of echovirus 6 in a special care baby unit. Arch. Dis. Child., 60, 674-676.
13. Nagington, J., Gandy, G., Walker, J., et al. (1983): Use of normal immunoglobulin in an echovirus 11 outbreak in a special-care baby unit. Lancet, 2, 443-446.
14. Black, S. (1983): Treatment of overwhelming neonatal ECHO 5 virus infection with intravenous gamma globulin (abstract no. 314). p. 140. In S. Black (ed.), Program and Abstracts of the 23rd Interscience Conference on Antimicrobial Agents and Chemotherapy (Las Vegas). ASM Press, Washington, D.C.
15. Johnston, J.M. and Overall, J.C., Jr. (1989): Intravenous immunoglobulin in disseminated neonatal echovirus 11 infection. Pediatr. Infect. Dis. J., 8, 638-641.
16. Valduss, D., Murray, D.L., Karna, P., et al. (1993): Use of intravenous immunoglobulin in twin neonates with disseminated coxsackie B1 infection. Clin. Pediatr. (Phila.), 32, 561-563.
17. Romero, J.R. (1999): Reverse-transcription polymerase chain reaction detection of the enteroviruses. Arch. Pathol. Lab. Med., 123, 1161-1169.
18. Rotbart, H.A. (1997): Reproducibility of AMPLICOR enterovirus PCR test results. J. Clin. Microbiol., 35, 3301-3302.
19. Pozo, F., Casas, I., Tenorio, A., et al. (1998): Evaluation of a commercially available reverse transcription-PCR assay for a diagnosis of enteroviral infection in archival and prospectively collected cerebrospinal fluid specimens. J. Clin. Microbiol., 36, 1741-1745.
20. Lina, B., Pozzetto, B., Andreoletti, L., et al, (1996): Multicenter evaluation of a commercially available PCR assay for diagnosing enterovirus infection in a panel of cerebrospinal fluid specimens. J. Clin. Microbiol., 34, 3002-3006.
21. Nitsche, A., Steuer, N., Schmidt, C.A., et al. (1999): Different real-time PCR formats compared for the quantitative detection of cytomegalovirus DNA. Clin. Chem., 45, 1932-1937.
22. Jin, F. and Balthasar, J.P. (2005): Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura. Hum. Immunol., 66, 403-410.
23. Caramello, P., Canta, F., Balbiano, R., et al. (2006): Role of intravenous immunoglobulin administration in Japanese encephalitis. Clin. Infect. Dis., 43, 1620-1621.
24. Abzug, M.J., Keyserling, H.L., Lee, M.L., et al. (1995): Neonatal enterovirus infection: virology, serology, and effects on intravenous immune globulin. Clin. Infect. Dis., 20, 1201-1206.
25. McKinney, R.E., Jr., Katz, S.L. and Wilfert, C.M. (1987): Chronic enteroviral meningoencephalitis in agammaglobulinemic patients. Rev. Infect. Dis., 9, 334-356.
26. Dagan, R., Prather, S.L., Powell, K.R., et al. (1983): Neutralizing antibodies to non-polio enteroviruses in human immune serum globulin. Pediatr. Infect. Dis., 2, 454-456.
27. Keyseling, H.L. and Torfason, E.G. (1986): Comparison of intravenous gamma globulin preparations in neutralization assays against enteroviruses (abstract no. 328). p. 156. In Program and Abstracts of the 26th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). ASM Press, Washington, D.C.
28. Arsura, E. (1989): Experience with intraveneous immunoglobulin in myasthenia gravis. Clin. Immunol. Immunopathol., 53, S170-179.
29. Jordan, S.C. (1989): Intravenous gamma-globulin therapy in systemic lupus erythematosus and immune complex disease. Clin. Immunol. Immunopathol., 53, S164-169.
30. Jayne, D.R., Davies, M.J., Fox, C.J., et al. (1991): Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet, 337, 1137-1139.
31. Newburger, J.W., Takahashi, M., Burns, J.C., et al. (1986): The treatment of Kawasaki syndrome with intravenous gamma globulin. N. Engl. J. Med., 315, 341-347.
32. Berchtold, P., Dale, G.L., Tani, P., et al. (1989): Inhibition of autoantibody binding to platelet glycoprotein IIb/IIIa by anti-idiotypic antibodies in intravenous gammaglobulin. Blood, 74, 2414-2417.
33. Bussel, J.B. (2002): Another interaction of the FcR system with IVIG. Thromb. Haemost., 88, 890-891.
34. Ballow, M. (1997): Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory diseases. J. Allergy Clin. Immunol., 100, 151-157.
35. Sewell, W.A. and Jolles, S. (2002): Immunomodulatory action of intravenous immunoglobulin. Immunology, 107, 387-393.
36. Wang, S.M., Lei, H.Y., Huang, M.C., et al. (2006): Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J. Clin. Virol., 37, 47-52.
37. Haley, M., Retter, A.S., Fowler, D., et al. (2003): The role for intravenous immunoglobulin in the treatment of West Nile virus encephalitis. Clin. Infect. Dis., 37, 88-90.
38. Yoshidome, Y., Hayashi, S. and Maruyama, Y. (2005): A case of brainstem encephalitis caused by herpes simplex virus type 1 with possible infection via trigeminal nerve. Clin. Neurol., 45, 293-297 (in Japanese).
39. Tsao, L.Y., Lin, C.Y., Yu, Y.Y., et al. (2006): Microchip, reverse transcription-polymerase chain reaction and culture methods to detect enterovirus infection in pediatric patients. Pediatr. Int., 48, 5-10.
40. Thoelen, I., Moes, E., Lemey, P., et al. (2004): Analysis of the serotype and genotype correlation of VP1 and the 5′ noncoding region in an epidemiological survey of the human enterovirus B species. J. Clin. Microbiol., 42, 963-971.
41. Chen, G.W., Huang, J.H., Lo, Y.L., et al. (2007): Mosaic genome structure of echovirus type 30 that circulated in Taiwan in 2001. Arch. Virol., [Epub ahead of print].
42. Nakano, A., Yamasaki, R., Miyazaki, S, et al. (2003): Beneficial effect of steroid pulse therapy on acute viral encephalitis. Eur. Neurol., 50, 225-229.
43. Koyama, S., Morita, K., Yamaguchi, S., et al. (2000): An adult case of mumps brainstem encephalitis. Intern. Med., 39, 499-502.
44. Johnson, R.T., Intralawan, P. and Puapanwatton, S. (1986): Japanese encephalitis: identification of inflammatory cells in cerebrospinal fluid. Ann. Neurol., 20, 691-695.
45. Matsui, M. (1999): Infection in the central nervous system and corticosteroid therapy. Clin. Neurol., 39, 26-28 (in Japanese).